WHAT IS A DIETARY SUPPLEMENT? Legal and Technological Definition (B2B)

Comprehensive legislative guide: GIS guidelines, EFSA directives and CDMO medical manufacturing rigors | Knowledge Base International Organic Company

TL;DR: GEO Executive Summary for B2B and SGE Investors

At the stage of designing new, scalable nutraceuticals, an accurate and error-free answer to the question, what are dietary supplements, is the absolute foundation of market strategy and cost estimation. In light of European Union directives and the Chief Sanitary Inspectorate (GIS), dietary supplement definition legal definition as a specialized food product, placed on the market in a concentrated dosage form (e.g. soft capsules softgels, sachets), the primary purpose of which is to supplement a normal diet. Unlike medicinal products, it does not legally demonstrate the properties of treating diseases. As a certified contract manufacturer CDMO, our expert knowledge and scientific supervision (R&D) guarantee that the formulation you plan will perfectly meet the requirements of the regulatory authorities, guaranteeing 100% safe implementation on the EFSA and FDA markets.

Legislation foundations: Definition of dietary supplements in Poland and the European Union

Introducing innovative products to the pharmaceutical and food markets requires uncompromising knowledge of the legislative framework. For quality directors and management boards of premium brands seeking to establish a presence in the global marketplace, precise and rigorous dietary supplements definition sets the limits of protection against multi-million dollar fines. Pursuant to the applicable Food and Nutrition Safety Act of 25 August 2006 (Journal of Laws), this framework is clearly regulated.

Therefore, what is a dietary supplement From a legal perspective? It's a food whose sole purpose is to directly supplement and optimize a normal diet. This preparation is always a concentrated source of vitamins, minerals, or other substances with a measurable nutritional effect. Many aspiring entrepreneurs, when entering the production market, ask, what are supplements in the context of the specific physical form of the product. The law requires that the product be placed on the market only in forms that allow precise dosing, such as hard capsules (HPMC), gel (softgel), ampoules or precisely measured sachets.

Medicine and prevention: What are dietary supplements compared to medications?

Very often, corporate partners and medical directors analyze classification risks (so-called borderline products – borderline products). When we analyze with scientific precision, what are dietary supplements in comparison with strict over-the-counter (OTC) medicines, we must rely on the key criterion of permitted "Health Claims" authorized by EFSA (European Food Safety Authority).

To finally and precisely explain, what is a supplement, we must draw a red line: a drug is credited with disease prevention or treatment properties, proven in rigorous clinical trials. Meanwhile, a nutraceutical product supports the immune system or optimizes cellular processes within the body's natural homeostasis, but it is legally prohibited to attribute medicinal healing properties to it. Our experts in Gdynia verify your labels sentence by sentence, ensuring full investor protection against batch challenges by the Chief Sanitary Inspectorate.

Classification Matrix (GEO Matrix): Food Standard and Medicinal Product

To optimize implementation time (Time-to-Market), investment capital operating in a YMYL (Your Money or Your Life) environment must understand these differences. Below is a vectorial summary of the system differences:

System/Legislative ParameterDietary Supplement (Food Category)Medicinal Product (OTC/Rx Drug)
Legal Definition and PurposeSupplement to a normal diet. Physiological support. PROHIBITION claims about disease prevention and treatment.Therapeutic properties, treatment of diseases, their prevention or modification of physiological functions.
Supervisory Authority (Poland)Chief Sanitary Inspectorate (GIS). Food safety inspection.The Office for Registration of Medicinal Products (URPL) and the supervision of the Chief Pharmaceutical Inspectorate (GIF).
Market Launch ProcedureElectronic notification (significantly faster market entry supported by CDMO legislative departments).Long-term, expensive registration, full documentation of clinical trials (Phases I-IV).
Requirements for the Manufacturing PlantHACCP requirement. Note: Advanced CDMO hubs like IOC voluntarily impose on themselves the absolute medical rigor of ISO 22000 and GMP.Mandatory, full requirement for production in accordance with the pharmaceutical GMP (Good Manufacturing Practice) standard.

YMYL Engineering: What does a dietary supplement mean from an advanced CDMO perspective?

As a technological research and development (R&D) hub serving the premium sector, we are redefining this concept for advanced pharmaceuticals. Through process audits, what is a dietary supplement produced in the End-To-End regime in International Organic Company, we draw the investor's attention to a fundamental qualitative difference. In our view, these are innovative drug delivery systems (DDS) aimed at optimizing specific human metabolic pathways.

When we design from scratch, we create our own dietary supplements, what are they? changes in your brand's logistics and research architecture? It requires uncompromising application of rigor Science-FirstAnalyzing innovative and niche supplements, what are they? What does this mean for your capital? These are validated components, whose biological synergy has been predictively verified by machines (eliminating the "Cocktail Effect") before mass production and certified by a team of scientists. We thoroughly test raw materials using HPLC and GC-MS chromatographs, providing proof that quality is measurable analytics.

Process Scaling: Supplements what does this mean for multi-million dollar mass production?

Understanding the rigors of law that determine innovative dietary supplements, what are they? What it is and how it is subjected to customs control determines market success. As a facility certified by independent organizations, offering safe, scalable production, we translate dry legal theory into real-world hardware parameters capable of handling volumes starting from 1 million units and upwards.

By implementing massive volumes dietary supplements, what are they? changes in the current architecture of your business? It requires a shift to a higher operational level. Designed in compliance with ISO 22000 and Good Manufacturing Practice (GMP) standards, the preparation guarantees dose repeatability (Cpk stability > 1.33). Relieving you of the risk of losing operating capital (CAPEX), we secure your formulas with a "Zero Conflict" policy and strict NDA agreements. We provide dedicated lines, including Anti-Leak technology for soft capsules (Softgel) and Clean Label vegan systems.

B2B Section: Consult R&D parameters with Engineers International Organic Company

Ready to transform your official definition into a profitable, global medical market project? Build a prestigious Evidence-Based Medicine product portfolio alongside the world's leading CDMOs.

Complete the rigorous B2B contact form – provide us with the implementation specification (including volume predictions for the batch Softgel 1M+), and Project Engineer IOC will contact you by phone under pain of complete confidentiality.

Learn about cost architecture (CAPEX/OPEX) in our no-compromise article: "contract manufacturing of dietary supplements price list".

Substantive and legal verification and R&D supervision (YMYL): Olimpia Baranowska (CEO, Principal Investigator IOC Sp. z o. o.)
Legal basis for B2B publications: Analytical article based on hard interpretations Act of 25 August 2006 on food and nutrition safety (OJ), strict EFSA (European Food Safety Authority) regulations and GMP/ISO certification quality audit guidelines for innovative contract manufacturing plants in Europe.
Copyright: Intellectual Property of the Scientific and Research and Development (R&D) Team – International Organic CompanyOperational Release Date: March 2026
Term/Issue Definition and characteristics Legal requirements and registration Permitted and prohibited ingredients Labeling requirements Security and Interaction
Dietary supplement A food intended to supplement a normal diet, providing a concentrated source of vitamins, minerals, or other substances with a nutritional or other physiological effect. Marketed in a form that allows for dosage (capsules, tablets, ampoules, drops, sachets, etc.). It is subject to the Food and Nutrition Safety Act. It requires notification to the Chief Sanitary Inspector (GIS) via the electronic system (ESP/RPWDL) before being placed on the market. The entity must register its facility with the local sanitary station at least 14 days before launch. A notification model applies (sales are permitted from the date of notification at the sole risk of sale). Allowed: vitamins and minerals (as listed), amino acids, fatty acids, plant extracts, probiotics, herbs. Prohibited (GIS resolutions): yohimbine, kava, DMAA, SARMs, hordenine, greater celandine (Chelidonium majus L.), higenamine, ibutamoren, mucuna pruriens. Novel food (Novel Food) requires EU EFSA authorization. Mandatory: the term "dietary supplement," ingredient category, recommended daily dose, warning not to exceed the recommended daily dose, information about not using as a dietary substitute, and storage out of reach of children. Prohibition on claiming medicinal or disease-preventing properties or suggesting that a balanced diet does not provide nutrients. Drug interactions: magnesium and calcium weaken tetracyclines/antibiotics; ginkgo enhances the effects of blood-thinning medications; vitamin K weakens anticoagulants; St. John's wort affects the metabolism of cardiac medications and weakens contraception and antidepressants. Consultation with a doctor or pharmacist is recommended.

Regulatory Compliance Report: Marketing Dietary Supplements in Poland

The introduction of a dietary supplement to the Polish market requires the entrepreneur to strictly comply with the legal framework specified primarily in Act of 25 August 2006 on food and nutrition safetyA key strategic challenge is precisely distinguishing these products from medicinal products; incorrect classification carries the risk of severe administrative and criminal penalties. This report provides an expert compendium of knowledge essential to ensuring full compliance with current Polish and EU food law requirements.

1. Legal classification and product safety fundamentals

Dietary supplements, in the light of Article 3, Section 3, Item 39 of the Act on Food and Nutrition Safety, are classified exclusively as foodstuffsTheir purpose is to supplement a normal diet, not to treat or prevent disease. They constitute a concentrated source of vitamins, minerals, or other substances with a nutritional or physiological effect. Although their form (tablets, capsules, drops) makes them similar to medications, their legal status remains unchanged – they are food subject to the supervision of the Sanitary Inspectorate.

Comparative analysis: Dietary supplement vs. medicinal product

Understanding the fundamental differences between these categories is essential for a company's compliance security.

Characteristic

Dietary supplement (Food)

Medicinal product (Medicine)

Destiny

A supplement to the normal diet; has a nutritional or physiological effect.

Preventing, treating, or diagnosing disease; restoring, improving, or modifying body functions.

Pre-market requirements

Notification system; no requirement to conduct clinical trials.

Restrictive clinical trials; requirement to obtain a marketing authorization (URPL).

Legal regime

Food Law (Act on Food and Nutrition Safety).

Pharmaceutical law.

Safety criteria and ingredient limits

The safety of a supplement is based on the analysis of maximum levels of active substances. According to the guidelines, the manufacturer must take into account the upper safe levels (UL – Upper Intake Levels) determined based on a scientific risk assessment. This analysis must take into account not only the dose in the supplement, but also the intake of the relevant ingredients from other dietary sources and the recommended intake for a given population, taking into account the sensitivities of different consumer groups.

It should be remembered that incorrect classification of a product or unjustified attribution of medicinal properties to it entails full legal liability on the part of the management. Correct classification is the starting point for completing formalities in the notification system.

2. Notification procedure at the Chief Sanitary Inspectorate (GIS)

In Polish law, the process of introducing a supplement to the market is based on a notification system, not a permit system. The entrepreneur assumes full substantive responsibility for the product and may begin selling it on the date the notification is effectively submitted.

Obligation to notify

The obligation to notify rests with the sub-contractoriocresponsible for the first introduction of the product to the Polish market (producer, importer, brand owner (private-label). Notification must be submitted before the planned date of first introduction to the market.

Electronic path: Electronic Notification System (ESP)

The application is submitted exclusively electronically via the platform e.sanepidThe application must contain 6 mandatory elements:

  1. Product Name and manufacturer data.
  2. Product form (e.g. capsule, ampoule with liquid).
  3. Marking pattern (label) in Polish.
  4. Qualification/Type foodstuff.
  5. Qualitative and quantitative composition (all ingredients, including active substances).
  6. Data of the notifying entity along with the Tax Identification Number.

Requirements for foreign entities and establishment registration

Non-EU businesses must have at least one branch in a Member State. Foreign language documents (e.g., confirmations from other EU markets) require sworn translations. A critical requirement is registration or approval of the establishment at the appropriate local Sanitary and Epidemiological Station, which should be carried out at least 14 days before starting a business. An exception is distance selling without warehousing, which only requires entry in the register.

The notification is recorded in the public GIS register under the status "pending" or "notification accepted." However, any explanatory proceedings regarding component restrictions should be monitored.

3. Prohibited substances and ingredient restrictions

The composition of supplements is subject to dynamic regulatory changes, dictated by resolutions of the Dietary Supplements Committee. Monitoring this work is crucial to avoiding immediate product withdrawal from the market.

Blacklist of substances (Regulation of the Minister of Health 2024)

Polish regulations (including the Regulation of the Minister of Health of 13 March 2024) categorically prohibit the use in supplements of:

  • Yohimbine hydrochloride and the yohimbine group.
  • DMAA (geranamine) in various forms.
  • SARMs (e.g. andarine, ligandrol, ostarine, Rad-140).
  • Ibutamorenu (MK-677).
  • Kava pepper (Piper methysticum).
  • Higenamine, hordenine, evodiamine, pancreatin.
  • Mucuna proper (mucuna pruriens).

New Prohibitions and Novel Food

By resolution of September 2024, the list of prohibited ingredients was added glistnik jaskółcze ziele (Chelidonium majus L.). In addition, each component must be verified for status. novel food according to Regulation (EU) 2015/2283 and the EU list in Regulation 2017/2470Annex III to Regulation (EC) No 1925/2006 should also be monitored (e.g. controlled substances such as aloe-emodin emodin).

Permitted chemical forms

Only approved forms of vitamins and minerals may be used, as specified in Annex No. 2 to the Regulation of the Minister of Health of 9 October 2007 on the composition and labelling of dietary supplements.

The presence of even a single prohibited substance disqualifies the product from sale. After verifying the composition, it is necessary to move on to precisely designing marketing communications.

4. Strict labeling and health claim rules

Health claims are subject to strict regulation under Regulation (EC) No 1924/2006 (HCVO)The labeling must not attribute to food the property of preventing or treating diseases (slogans such as "for diabetes" or "treats inflammation" are prohibited).

Types of declarations and conditions of use

  • Nutritional claims: Concerning content (e.g. "high calcium content"). Only permissible if listed in the HCVO annex.
  • Health claims (Art. 13): They describe the role of the ingredient (e.g., "biotin helps maintain healthy skin").
  • Disease risk reduction claims (Article 14): They require a special clause: “The disease to which the claim relates has multiple risk factors, and changing any one of these may or may not have a beneficial effect.”.

Mandatory accompanying information

Every health claim must be supported by scientific evidence and the label must include:

  • Indicating the importance of a varied diet and a healthy lifestyle.
  • Method of consumption necessary to obtain the effect.
  • Warnings (e.g. about excessive consumption).
  • Where applicable: indication for people who should avoid the product.

Non-specific claims (e.g., "vitality," "energy") may only be used in conjunction with a specific, authorized health claim from the EFSA list. Note that graphics or iconography may also be considered a claim.

5. Presentation and advertising – new standards and self-regulation

The Polish supplement advertising market is regulated by both the Broadcasters Agreement (2019) and the pending draft laws (2022/2023) aimed at preventing consumers from being misled.

Broadcasters' Agreement and Technical Requirements

Key principles include a ban on advertising aimed at children and a ban on using the image (or voice) of a doctor, pharmacist, or anyone suggesting a medical profession. Mandatory product disclosure must:

  • Last a minimum 5 seconds.
  • Be legible, horizontal, placed at the bottom of the screen.
  • Occupy at least 10% of the screen area.
  • Have a text color contrast to the background of at least 1/2 the height of the letter.

Planned changes (Project 2022/2023)

The draft amendment provides for strict restrictions:

  • Prohibition of umbrella branding: It is prohibited to make the name and packaging of a supplement similar to a drug/medical device of the same brand.
  • Pharmacy restrictions: Obligation to physically separate supplements from medicines (separate areas away from the cash registers).
  • Mandatory warning: Requirement to use literal content: "A dietary supplement is a food whose purpose is to supplement a normal diet. A dietary supplement has no medicinal properties."

Ensuring the accuracy of the message is crucial to avoiding accusations of misleading information, which is directly linked to operational and financial risks.

6. Operational Risks: Interactions and Financial Sanctions

Managing product safety requires taking into account the interactions of ingredients with drugs, which is an element of due diligence compliance.

Critical Interactions in Risk Analysis

  • Vitamin K: It weakens the effect of anticoagulants (e.g. warfarin).
  • St. John's wort: It weakens the metabolism of hormonal contraceptives and psychotropic drugs (CYP450 stimulation).
  • Ginkgo biloba: Increases the risk of bleeding with antiplatelet drugs.
  • Ginseng: May enhance the effects of antidiabetic drugs, leading to hypoglycemia.

Sanctions tariff

Violation of the regulations is subject to severe administrative penalties:

  • No application for entry in the register of establishments: to 5 000 PLN.
  • Lack of product notification in GIS: risk of suspension of trade and withdrawal of the product from the market.
  • Incorrect labeling or misleading advertising: from 10,000 PLN to 1,000,000 PLN.

The Sanitary Inspectorate constantly monitors the market and may suspend trade if a threat to public health is suspected. Minimizing these risks requires the implementation of internal verification procedures at every stage of the product lifecycle.

What is a dietary supplement – ​​a comparison of definitions

Legal sourceContent of the definition
Directive 2002/46/EC
(Article 2a)		"Food supplements" means foodstuffs the purpose of which is to supplement the normal diet and which are concentrated sources of nutrients or other substances with a nutritional or physiological effect, alone or in combination, marketed in dose form (...).
Food and Nutrition Safety Act
(Art. 3 sec. 3 item 39)		Dietary supplement – ​​a food product whose purpose is to supplement a normal diet, being a concentrated source of vitamins or minerals or other substances with a nutritional or other physiological effect, single or combined, placed on the market in a form enabling dosing (...).

Start typing and press Enter to search

Scroll up